Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1969;3:11–18.

The effect of oral contraceptives on cortisol metabolism

C W Burke
PMCID: PMC1436049

Abstract

The administration of oral contraceptives which contain oestrogen increases non-protein-bound plasma cortisol levels at 9 am as well as protein-bound and total cortisol levels. These increases are dependent on the dose of oestrogen; they are not usually seen with progestogen-only or `low-dose' oestrogen (0·05 mg mestranol or less) preparations. `Standard' oral contraceptives (0·1 mg mestranol or equivalent) produce some elevation of unbound cortisol levels at 9 am (from a normal mean of 0·66 μg/100 ml to 1·02 on the `pill') but this elevation is less than that associated with high-dose oestrogen treatment of, for example, prostate cancer (mean 1·8 μg/100 ml). Since unbound cortisol levels in plasma are controlled by a hypothalamic feedback mechanism, it appears that oral contraceptives have some effect on this mechanism. Possible long-term effects of oral contraceptives on hypothalamopituitary function require examination.

However, the plasma unbound cortisol to which the tissues are exposed at 9 am does not measure the overall exposure of tissues to cortisol throughout the 24 hours. Neither does measurement of cortisol production rate or urinary metabolite excretion accurately reflect the exposure of tissues to cortisol during oestrogen treatment, because of the complex effects of oestrogen on hepatic metabolism of steroids, steroid-protein binding, and the increased size of the extracellular cortisol pool.

The overall exposure of tissues to unbound cortisol is measured better by urinary free cortisol excretion. Urinary free cortisol excretion is a measure of the integrated area under the diurnal curve of plasma unbound cortisol, ie, of the 24-hour exposure of tissues to unbound cortisol. Urinary free cortisol excretion is normal in women taking low-dose oestrogen or progestogen-only contraceptives, and is only trivially increased by the standard `pill'. Thus increased exposure of tissues to unbound cortisol is likely to be only a minor factor in the metabolic responses to oral contraceptives. In contrast, urinary free cortisol excretion (mean normal 38 μg/24 hours) is increased by high-dose oestrogen administration for prostatic cancer (mean 110 μg/24 hours); this is because the diurnal rhythm of unbound cortisol is impaired.

It is thus unwise to ascribe effects of oral contraceptives to increased exposure of tissues to cortisol, except in the liver where it is possible that the increased concentration of protein-bound cortisol they cause may exert metabolic effects. The preparations which cause least change in cortisol metabolism are the low-dose oestrogen or progestogen-only contraceptives.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEISEL W. R., COS J. J., HORTON R., CHAO P. Y., FORSHAM P. H. PHYSIOLOGY OF URINARY CORTISOL EXCRETION. J Clin Endocrinol Metab. 1964 Sep;24:887–893. doi: 10.1210/jcem-24-9-887. [DOI] [PubMed] [Google Scholar]
  2. Blecher M. Serum protein-steroid hormone interactions. Effects of glucocorticoids on glucose metabolism in rat adipose isolated cells, and the influence of human plasma corticosteroid binding protein. Endocrinology. 1966 Sep;79(3):541–546. doi: 10.1210/endo-79-3-541. [DOI] [PubMed] [Google Scholar]
  3. Burke C. W. Accurate measurement of steroid-protein binding by steady-state gel filtration. Biochim Biophys Acta. 1969 Mar 4;176(2):403–413. doi: 10.1016/0005-2760(69)90199-4. [DOI] [PubMed] [Google Scholar]
  4. Burke C. W. Biologically active cortisol in plasma of oestrogen-treated and normal subjects. Br Med J. 1969 Jun 28;2(5660):798–800. doi: 10.1136/bmj.2.5660.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burke C. W., Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br Med J. 1970 Mar 14;1(5697):657–659. doi: 10.1136/bmj.1.5697.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DOE R. P., FERNANDEZ R., SEAL U. S. MEASUREMENT OF CORTICOSTEROID-BINDING GLOBULIN IN MAN. J Clin Endocrinol Metab. 1964 Oct;24:1029–1039. doi: 10.1210/jcem-24-10-1029. [DOI] [PubMed] [Google Scholar]
  7. DOE R. P., ZINNEMAN H. H., FLINK E. B., ULSTROM R. A. Significance of the concentration of nonprotein-bound plasma cortisol in normal subjects, Cushing's syndrome, pregnancy, and during estrogen therapy. J Clin Endocrinol Metab. 1960 Nov;20:1484–1492. doi: 10.1210/jcem-20-11-1484. [DOI] [PubMed] [Google Scholar]
  8. De Moor P., Steeno O., Brosens I., Hendrikx A. Data on transcortin activity in human plasma as studied by gel filtration. J Clin Endocrinol Metab. 1966 Jan;26(1):71–78. doi: 10.1210/jcem-26-1-71. [DOI] [PubMed] [Google Scholar]
  9. Doe R. P., Dickinson P., Zinneman H. H., Seal U. S. Elevated nonprotein-bound cortisol (NPC) in pregnancy, during estrogen administration and in carcinoma of the prostate. J Clin Endocrinol Metab. 1969 Jun;29(6):757–766. doi: 10.1210/jcem-29-6-757. [DOI] [PubMed] [Google Scholar]
  10. Doe R. P., Mellinger G. T., Swaim W. R., Seal U. S. Estrogen dosage effects on serum proteins: a longitudinal study. J Clin Endocrinol Metab. 1967 Aug;27(8):1081–1086. doi: 10.1210/jcem-27-8-1081. [DOI] [PubMed] [Google Scholar]
  11. Espiner E. A. Urinary cortisol excretion in stress situations and in patients with Cushing's syndrome. J Endocrinol. 1966 May;35(1):29–44. doi: 10.1677/joe.0.0350029. [DOI] [PubMed] [Google Scholar]
  12. Kawai A., Yates F. E. Interference with feedback inhibition of adrenocorticotropin release by protein binding of corticosterone. Endocrinology. 1966 Dec;79(6):1040–1046. doi: 10.1210/endo-79-6-1040. [DOI] [PubMed] [Google Scholar]
  13. Keller N., Richardson U. I., Yates F. E. Protein binding and the biological activity of corticosteroids: in vivo induction of hepatic and pancreatic alanine aminotransferases by corticosteroids in normal and estrogen-treated rats. Endocrinology. 1969 Jan;84(1):49–62. doi: 10.1210/endo-84-1-49. [DOI] [PubMed] [Google Scholar]
  14. LAYNE D. S., MEYER C. J., VAISHWANAR P. S., PINCUS G. The secretion and metabolism of cortisol and aldosterone in normal and in steroid-treated women. J Clin Endocrinol Metab. 1962 Feb;22:107–118. doi: 10.1210/jcem-22-2-107. [DOI] [PubMed] [Google Scholar]
  15. MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962 Jul;15:374–379. doi: 10.1136/jcp.15.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MILLS I. H., SCHEDL H. P., CHEN P. S., Jr, BARTTER F. C. The effect of estrogen administration on the metabolism and protein binding of hydrocortisone. J Clin Endocrinol Metab. 1960 Apr;20:515–528. doi: 10.1210/jcem-20-4-515. [DOI] [PubMed] [Google Scholar]
  17. Matsui N., Plager J. E. In vitro physiological activity of protein-bound and unbound cortisol. Endocrinology. 1966 Jun;78(6):1159–1164. doi: 10.1210/endo-78-6-1159. [DOI] [PubMed] [Google Scholar]
  18. Murphy B. E. Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay. J Clin Endocrinol Metab. 1968 Mar;28(3):343–348. doi: 10.1210/jcem-28-3-343. [DOI] [PubMed] [Google Scholar]
  19. Murray D. Cortisol binding to plasma proteins in man in health, stress and at death. J Endocrinol. 1967 Dec;39(4):571–591. doi: 10.1677/joe.0.0390571. [DOI] [PubMed] [Google Scholar]
  20. Musa B. U., Doe R. P., Seal U. S. Serum protein alterations produced in women by synthetic estrogens. J Clin Endocrinol Metab. 1967 Oct;27(10):1463–1469. doi: 10.1210/jcem-27-10-1463. [DOI] [PubMed] [Google Scholar]
  21. O'Connell M., Welsh G. W., 3rd Unbound plasma cortisol in pregnant and Enovid-E treated women as determined by ultrafiltration. J Clin Endocrinol Metab. 1969 Apr;29(4):563–568. doi: 10.1210/jcem-29-4-563. [DOI] [PubMed] [Google Scholar]
  22. PETERSON R. E., NOKES G., CHEN P. S., Jr, BLACK R. L. Estrogens and adrenocortical function in man. J Clin Endocrinol Metab. 1960 Apr;20:495–514. doi: 10.1210/jcem-20-4-495. [DOI] [PubMed] [Google Scholar]
  23. PLAGER J. E., SCHMIDT K. G., STAUBITZ W. J. INCREASED UNBOUND CORTISOL IN THE PLASMA OF ESTROGEN-TREATED SUBJECTS. J Clin Invest. 1964 Jun;43:1066–1072. doi: 10.1172/JCI104990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. ROBERTSON M. E., STIEFEL M., LAIDLAW J. C. The influence of estrogen on the secretion, disposition and biologic activity of cortisol. J Clin Endocrinol Metab. 1959 Nov;19:1381–1398. doi: 10.1210/jcem-19-11-1381. [DOI] [PubMed] [Google Scholar]
  25. SANDBERG A. A., SLAUNWHITE W. R., Jr, CARTER A. C. Transcortin: a corticosteroid-binding protein of plasma. III. The effects of various steroids. J Clin Invest. 1960 Dec;39:1914–1926. doi: 10.1172/JCI104216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SANDBERG A. A., SLAUNWHITE W. R., Jr Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J Clin Invest. 1959 Aug;38(8):1290–1297. doi: 10.1172/JCI103904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SANDBERG A. A., WOODRUFF M., ROSENTHAL H., NIENHOUSE S., SLAUNWHITE W. R., Jr TRANSCORTIN: A CORTICOSTEROID-BINDING PROTEIN OF PLASMA. VII. HALF-LIFE IN NORMAL AND ESTROGEN-TREATED SUBJECTS. J Clin Invest. 1964 Mar;43:461–466. doi: 10.1172/JCI104931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. SLAUNWHITE W. R., LOCKIE G. N., BACK N., SANDBERG A. A. Inactivity in vivo of transcortin-bound cortisol. Science. 1962 Mar 23;135(3508):1062–1063. doi: 10.1126/science.135.3508.1062. [DOI] [PubMed] [Google Scholar]
  29. Vagnucci A. I., Hesser M. E., Kozak G. P., Pauk G. L., Lauler D. P., Thorn G. W. Circadian cycle of urinary cortisol in healthy subjects and in Cushing's syndrome. J Clin Endocrinol Metab. 1965 Oct;25(10):1331–1339. doi: 10.1210/jcem-25-10-1331. [DOI] [PubMed] [Google Scholar]
  30. Zinneman H. H., Seal U. S., Doe R. P. Urinary amino acids in pregnancy, following progesterone, and estrogen-progesterone. J Clin Endocrinol Metab. 1967 Mar;27(3):397–405. doi: 10.1210/jcem-27-3-397. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES